Literature DB >> 12199159

Changes of the level of G protein alpha-subunit mRNA by tolerance to and withdrawal from pentobarbital in rats.

Younghwa Kim1, Seikwan Oh.   

Abstract

Pentobarbital was continuously infused intracerebroventricularly (i.c.v.) at the rate of 300 micrograms/10 microliters/h for 7 days, and withdrawal from pentobarbital was rendered 24 h after the stopping of the infusion. To eliminate the induction of hepatic metabolism by systemic administration of pentobarbital, an i.c.v. infusion model of tolerance to and withdrawal from pentobarbital was used. Little is known about the functional modulation of the G protein alpha-subunits at the molecular level. The effects of continuous infusion of pentobarbital on the modulation of G protein alpha-subunits mRNA were investigated by using in situ hybridization study. In situ hybridization showed that the level of G alpha s mRNA was increased in the septum and brainstem, and the level of G alpha o mRNA was elevated in the cortex during the pentobarbital withdrawal. The level of G alpha i mRNA was significantly elevated in almost all area of brain during the pentobarbital withdrawal. These results suggest that region-specific changes of G protein alpha-subunit mRNA were involved in the withdrawal from pentobarbital, whereas alpha-subunit is not so highly involved in the pentobarbital tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199159     DOI: 10.1023/a:1019808905500

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Different beta-subunits determine G-protein interaction with transmembrane receptors.

Authors:  C Kleuss; H Scherübl; J Hescheler; G Schultz; B Wittig
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

2.  Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons.

Authors:  R L Macdonald; J L Barker
Journal:  Science       Date:  1978-05-19       Impact factor: 47.728

3.  Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system.

Authors:  M K Ticku; R W Olsen
Journal:  Life Sci       Date:  1978-05-08       Impact factor: 5.037

Review 4.  Signal sorting and amplification through G protein-coupled receptors.

Authors:  E M Ross
Journal:  Neuron       Date:  1989-08       Impact factor: 17.173

5.  Changes in [3H]forskolin binding to adenylate cyclase and [3H]phorbol dibutyrate binding to protein kinase C in pentobarbital tolerant/dependent rats.

Authors:  S Oh; S E Wellman; I K Ho
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

6.  Role of NMDA receptors in pentobarbital tolerance/dependence.

Authors:  S Oh; K Hoshi; I K Ho
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

7.  Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain.

Authors:  A L Morrow; P Montpied; A Lingford-Hughes; S M Paul
Journal:  Alcohol       Date:  1990 May-Jun       Impact factor: 2.405

8.  Evidence that barbiturates inhibit antigen-induced responses through interactions with a GTP-binding protein in rat basophilic leukemia (RBL-2H3) cells.

Authors:  A J Robinson-White; S M Muldoon; L Elson; D M Collado-Escobar
Journal:  Anesthesiology       Date:  1990-06       Impact factor: 7.892

9.  Anesthetic barbiturates enhance Gs alpha-dependent cyclic AMP production in S49 mouse lymphoma cells.

Authors:  J M Gonzales
Journal:  J Neurochem       Date:  1995-06       Impact factor: 5.372

10.  Brain noradrenergic systems as a prerequisite for developing tolerance to barbiturates.

Authors:  B Tabakoff; J Yanai; R F Ritzmann
Journal:  Science       Date:  1978-04-28       Impact factor: 47.728

View more
  1 in total

Review 1.  Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; Tomohiro Tatsuta; Yoshio Morita; Motohiko Takemura; Xiao-Bing Wang; George R Uhl
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.